Cover Image
市場調查報告書

正子斷層掃描 (PET) 設備的全球市場:醫療設備的開發平台評估

Positron Emission Tomography (PET) Systems - Medical Devices Pipeline Assessment, 2017

出版商 GlobalData 商品編碼 358892
出版日期 內容資訊 英文 79 Pages
訂單完成後即時交付
價格
Back to Top
正子斷層掃描 (PET) 設備的全球市場:醫療設備的開發平台評估 Positron Emission Tomography (PET) Systems - Medical Devices Pipeline Assessment, 2017
出版日期: 2017年06月14日 內容資訊: 英文 79 Pages
簡介

本報告提供全球正子斷層掃描 (以下簡稱PET) 系統市場上的主要開發中產品 (醫療設備) 及其臨床實驗的進展調查,再加上產品的功能·特性比較分析 (臨床實驗的各進展階段) ,再彙整主要企業簡介及代表性產品,近來的市場動靜 (業績報告·資本交易趨勢等) 資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 正子斷層掃描 (PET) 系統概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期
  • 現在進行中的臨床實驗

第4章 臨床實驗中的開發中產品:各企業

  • PET設備的企業:各臨床實驗階段的開發中產品
  • PET設備:各臨床實驗階段的開發中產品

第5章 PET設備市場:企業·產品概要

  • Brain Biosciences Inc
    • 開發中產品及進行中的臨床實驗概要
  • GE Healthcare Limited
  • Jagiellonian University
  • Philips Healthcare
  • Ray Vision Intl Corp.
  • Stanford University
  • SynchroPET
  • The University of British Columbia
  • Zecotek Photonics Inc.

第6章 PET設備市場:目前的趨勢

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

GlobalData's Medical Devices sector report, "Positron Emission Tomography (PET) Systems - Medical Devices Pipeline Assessment, 2017" provides an overview of Positron Emission Tomography (PET) Systems currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Positron Emission Tomography (PET) Systems pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Positron Emission Tomography (PET) Systems under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Positron Emission Tomography (PET) Systems and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Positron Emission Tomography (PET) Systems under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 5
  • 1.2 List of Figures 6

2 Introduction 7

  • 2.1 Positron Emission Tomography (PET) Systems Overview 7

3 Products under Development 8

  • 3.1 Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development 8
  • 3.2 Positron Emission Tomography (PET) Systems - Pipeline Products by Territory 9
  • 3.3 Positron Emission Tomography (PET) Systems - Pipeline Products by Regulatory Path 10
  • 3.4 Positron Emission Tomography (PET) Systems - Pipeline Products by Estimated Approval Date 11

4 Positron Emission Tomography (PET) Systems - Pipeline Products under Development by Companies 12

  • 4.1 Positron Emission Tomography (PET) Systems Companies - Pipeline Products by Stage of Development 12
  • 4.2 Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development 13

5 Positron Emission Tomography (PET) Systems Companies and Product Overview 14

  • 5.1 Brain Biosciences Inc Company Overview 14
    • 5.1.1 Brain Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 14
  • 5.2 GE Healthcare LLC Company Overview 15
    • 5.2.1 GE Healthcare LLC Pipeline Products & Ongoing Clinical Trials Overview 15
  • 5.3 General De Equipment for Medical Imaging SA Company Overview 16
    • 5.3.1 General De Equipment for Medical Imaging SA Pipeline Products & Ongoing Clinical Trials Overview 16
  • 5.4 Jagiellonian University Company Overview 17
    • 5.4.1 Jagiellonian University Pipeline Products & Ongoing Clinical Trials Overview 17
  • 5.5 Philips Healthcare Company Overview 18
    • 5.5.1 Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 18
  • 5.6 Ray Vision Intl Corp. Company Overview 19
    • 5.6.1 Ray Vision Intl Corp. Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.7 Stanford University Company Overview 20
    • 5.7.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.8 SynchroPET Company Overview 25
    • 5.8.1 SynchroPET Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.9 University of British Columbia Company Overview 27
    • 5.9.1 University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.10 University of Washington Company Overview 28
    • 5.10.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview 28
  • 5.11 West Virginia University Company Overview 31
    • 5.11.1 West Virginia University Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.12 Zecotek Photonics Inc Company Overview 32
    • 5.12.1 Zecotek Photonics Inc Pipeline Products & Ongoing Clinical Trials Overview 32

6 Positron Emission Tomography (PET) Systems- Recent Developments 33

  • 6.1 Jun 12, 2017: Kieran Murphy Appointed CEO of GE Healthcare, Succeeding John Flannery 33
  • 6.2 May 31, 2017: Advanced Accelerator Applications Reports 21% Sales Growth for First Quarter 2017 34
  • 6.3 May 30, 2017: Zecotek Receives $100,000 Order for Patented LFS Scintillation Crystals from Major Chinese OEM 35
  • 6.4 May 25, 2017: Chinese OEMs Qualify LFS Scintillation Crystals for use in Positron Emission Tomography Medical Scanning Devices 36
  • 6.5 May 25, 2017: Advanced Accelerator Applications Appoints Christine Mikail to Board of Directors 36
  • 6.6 May 15, 2017: Threshold Pharmaceuticals Reports First Quarter Financial Results 37
  • 6.7 Apr 07, 2017: PET radiotracer design for monitoring targeted immunotherapy 38
  • 6.8 Mar 27, 2017: Threshold Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results 39
  • 6.9 Mar 23, 2017: Advanced Accelerator Applications Reports 23% Sales Growth for Fiscal 2016; Continued NETSPOT Launch Success 41
  • 6.10 Mar 21, 2017: Zecotek Provides Update to Chinese PET OEM MOU 42
  • 6.11 Mar 21, 2017: AMITA Health Offers Unique Opportunity For Medicare Recipients To Determine Whether They Have Alzheimer's 43
  • 6.12 Mar 09, 2017: Shanghai EBO Optoelectronics Company to Exclusively use Zecotek LFS Scintillation Crystals in China 45
  • 6.13 Feb 14, 2017: Care and convenience for patients with new PET scanner at St George Hospital 45
  • 6.14 Feb 14, 2017: ADDvise receives order from Consto AS worth 2,9 MNOK 46
  • 6.15 Jan 25, 2017: Zecotek Signs LFS Scintillation Crystal Supply Agreement Worth $21 million Over the Next 3 Years 46
  • 6.16 Dec 08, 2016: Advanced Accelerator Applications Announces CMS Pass-Through Reimbursement Code for its First FDA Approved Drug NETSPOT 47
  • 6.17 Dec 07, 2016: Progenics Pharmaceuticals Announces First Patient Dosed in Phase 2/3 Clinical Trial of PSMA-Targeted PET/CT Imaging Agent PyL 48
  • 6.18 Nov 28, 2016: Advanced Accelerator Applications Reports 15.4% Sales Growth in the Third Quarter of 2016 48
  • 6.19 Nov 15, 2016: Rocky Mountain Cancer Centers First In Region to Offer Newly Approved Gallium DOTATATE PET/CT for Neuroendocrine Tumors 49
  • 6.20 Nov 07, 2016: Threshold Pharmaceuticals Reports Third Quarter Financial Results 50
  • 6.21 Nov 02, 2016: Advanced Accelerator Applications Announces Swiss Marketing Authorization for Two PET Diagnostic Products 52
  • 6.22 Nov 01, 2016: GE Healthcare enhances single-use manufacturing capabilities with facility expansion and automation 52
  • 6.23 Nov 01, 2016: Neuraceq Automated Synthesizer Synthera Received Shonin Approval in Japan 53
  • 6.24 Oct 24, 2016: The Journal of Urology Publishes Blue Earth Diagnostics' Phase 3 Study Results of Axumin for PET Imaging of Recurrent Prostate Cancer 54
  • 6.25 Oct 13, 2016: Chinese OEM Orders Zecotek's LFS Scintillation Crystals for Third Scanner 55
  • 6.26 Oct 08, 2016: Oncovision will develop a technology for the early diagnosis of Alzheimer's disease 56
  • 6.27 Oct 05, 2016: Mayo Clinic researchers map prostate cancer relapse using C-11 choline PET and MRI 57
  • 6.28 Oct 04, 2016: Zecotek Announces Preliminary Revenue for Fiscal 2016 58
  • 6.29 Oct 03, 2016: Jubilant DraxImage Receives FDA Approval for RUBY-FILL Rubidium 82 Generator and Elution System 58
  • 6.30 Sep 26, 2016: FluoroPharma Announces CardioPET Phase II Results at the 21st American Society of Nuclear Cardiology (ASNC) Meeting 59
  • 6.31 Sep 22, 2016: EMA Recommends Granting a Marketing Authorisation for Edotreotide 60
  • 6.32 Sep 22, 2016: Lantheus to Present New Data at the ASNC Annual Scientific Session on the Novel PET Cardiac Imaging Agent Flurpiridaz F 18 in Patients with Suspected Heart Disease Undergoing Exercise Stress Testing 61
  • 6.33 Sep 07, 2016: Bruker Unveils Next-Generation Preclinical Imaging Systems for Advanced Translational Research at World Molecular Imaging Congress 62
  • 6.34 Aug 31, 2016: Advanced Accelerator Applications Reports 24.4% Sales Growth in the Second Quarter of 2016 63
  • 6.35 Aug 03, 2016: Advanced Accelerator Applications Announces First Administration of NETSPOT™ at Holy Name Medical Center 64
  • 6.36 Aug 01, 2016: Threshold Pharmaceuticals Reports Second Quarter Financial Results 65
  • 6.37 Jul 28, 2016: Update on Chinese OEM Building PET Scanners 67
  • 6.38 Jul 27, 2016: New Studies Suggest Relationship Between Tau Pathology And Progression Of Alzheimer's Disease 68
  • 6.39 Jul 18, 2016: MabVax Therapeutics Initiates Patient Enrollment in a Phase I Trial for a New Diagnostic Imaging Product for Pancreatic Cancer 70
  • 6.40 Jul 12, 2016: UCDavis Orders More LFS Crystals 70
  • 6.41 Jul 12, 2016: Oncodesign Announces the Launch of Its First Clinical Study on a Radiotracer in Patients with Non-Small Cell Lung Cancer 71
  • 6.42 Jul 08, 2016: New funding for the harmonisation and alignment of brain imaging methods 72
  • 6.43 Jul 07, 2016: Two SwedishAmerican Physician Executives Assume New Positions 73
  • 6.44 Jun 30, 2016: Zecotek receives second LFS Scintillation order for Radiation Safety and Homeland Security 73
  • 6.45 Jun 24, 2016: Genome British Columbia Investing in Companies and Jobs Through e@UBC 74

7 Appendix 76

  • 7.1 Methodology 76
  • 7.2 About GlobalData 79
  • 7.3 Contact Us 79
  • 7.4 Disclaimer 79

List of Tables

1.1 List of Tables

  • Table 1: Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development 8
  • Table 2: Positron Emission Tomography (PET) Systems - Pipeline Products by Territory 9
  • Table 3: Positron Emission Tomography (PET) Systems - Pipeline Products by Regulatory Path 10
  • Table 4: Positron Emission Tomography (PET) Systems - Pipeline Products by Estimated Approval Date 11
  • Table 5: Positron Emission Tomography (PET) Systems Companies - Pipeline Products by Stage of Development 12
  • Table 6: Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development 13
  • Table 7: Brain Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 14
  • Table 8: CerePET - Product Status 14
  • Table 9: CerePET - Product Description 14
  • Table 10: GE Healthcare LLC Pipeline Products & Ongoing Clinical Trials Overview 15
  • Table 11: Q.Clear - Product Status 15
  • Table 12: Q.Clear - Product Description 15
  • Table 13: General De Equipment for Medical Imaging SA Pipeline Products & Ongoing Clinical Trials Overview 16
  • Table 14: CareMiBrain - Product Status 16
  • Table 15: CareMiBrain - Product Description 16
  • Table 16: Jagiellonian University Pipeline Products & Ongoing Clinical Trials Overview 17
  • Table 17: Positron Emission Tomography System - Product Status 17
  • Table 18: Positron Emission Tomography System - Product Description 17
  • Table 19: Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 18
  • Table 20: Additional PET Scan - Product Status 18
  • Table 21: Additional PET Scan - Product Description 18
  • Table 22: Ray Vision Intl Corp. Pipeline Products & Ongoing Clinical Trials Overview 19
  • Table 23: Helmet - PET System - Product Status 19
  • Table 24: Helmet - PET System - Product Description 19
  • Table 25: Stanford University Pipeline Products & Ongoing Clinical Trials Overview 20
  • Table 26: Breast-Dedicated PET System - Product Status 20
  • Table 27: Breast-Dedicated PET System - Product Description 21
  • Table 28: Dual Panel PET Scanner - Product Status 21
  • Table 29: Dual Panel PET Scanner - Product Description 21
  • Table 30: Dual-isotope Positron Emitting Tomography System - Product Status 22
  • Table 31: Dual-isotope Positron Emitting Tomography System - Product Description 22
  • Table 32: MR Compatible PET System - Product Status 22
  • Table 33: MR Compatible PET System - Product Description 23
  • Table 34: PET Sensitivity Enhancing Device - Product Status 23
  • Table 35: PET Sensitivity Enhancing Device - Product Description 23
  • Table 36: PET System - Product Status 24
  • Table 37: PET System - Product Description 24
  • Table 38: SynchroPET Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 39: Breast PET-MRI - Product Status 25
  • Table 40: Breast PET-MRI - Product Description 25
  • Table 41: Wrist Scanner - Product Status 26
  • Table 42: Wrist Scanner - Product Description 26
  • Table 43: University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview 27
  • Table 44: PET Imaging Tool - Product Status 27
  • Table 45: PET Imaging Tool - Product Description 27
  • Table 46: University of Washington Pipeline Products & Ongoing Clinical Trials Overview 28
  • Table 47: DS-PS3 Positron Emission Tomography Detector - Product Status 28
  • Table 48: DS-PS3 Positron Emission Tomography Detector - Product Description 28
  • Table 49: High Resolution PET Detector - Product Status 29
  • Table 50: High Resolution PET Detector - Product Description 29
  • Table 51: PET-Mammogram-Biopsy System - Product Status 29
  • Table 52: PET-Mammogram-Biopsy System - Product Description 30
  • Table 53: West Virginia University Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 54: Positron Emission Tomography (PET) Imager - Product Status 31
  • Table 55: Positron Emission Tomography (PET) Imager - Product Description 31
  • Table 56: Zecotek Photonics Inc Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 57: New Generation PET Scanning Device - Product Status 32
  • Table 58: New Generation PET Scanning Device - Product Description 32
  • Table 59: Glossary 78

List of Figures

1.2 List of Figures

  • Figure 1: Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development 8
  • Figure 2: Positron Emission Tomography (PET) Systems - Pipeline Products by Territory 9
  • Figure 3: Positron Emission Tomography (PET) Sys
Back to Top